.

2553

Acetylcysteine (Fluimucil) 300 mg / 3 ml

Acyclovir powder 250 mg
Adrenaline 1 mg/ml
Adenosine (Adenocor) 6 mg / 2 ml
Antivenom
Amikacin 500 mg/ 2 ml
Amoxycillin/Clavulonic (Augmentin) 1.2g
Aminophylline 250 mg/10 ml
Amiodarone 150 mg / 3 m l
Amphotericin B powder 50 mg
Ampicillin powder 250 mg, 1 g
Atracurium besylate (Tracium) 50mg/5ml
Atropine sulfate 0.6 mg/ml
Azithromycin powder 500 mg
Calcium folinate (Leucovorin) 100 mg
Calcitonin Salmon 100 iu/ml
Calcium gluconate 1 g / 10 ml (10%)
Cefazolin powder 1 g
Cefotaxime powder 500 mg , 1 g
Cefoxitin powder 1 g
Ceftazidime (Fortum) powder 1 g
Ceftriaxone powder 1 g
Chloramphenicol powder 1 g
Chlorpheniramine 10 mg/ml
Chlorpromazine 50 mg in 2 ml

5
5
5
6
6
6
6
7
7
8
8
8
8
8
8
9
9
9
9
9
10
10
10
10
10

Ciprofloxacin 200 mg / 100 ml

Clindamycin (Dalacin C) 150 mg/ ml
Cloxacillin powder 500 mg, 1 g
Dexamethasone 4 mg/ml
Diazepam 10 mg/ 2 ml
Diclofenac 75 mg/ 3 ml
Digoxin 0.5 mg/2 ml
Dimenhydrinate 50 mg / ml
Dobutamine 250 mg / 20 ml
Dopamine 250 mg / 10 ml
Enoxaparin (Clexane) 40 mg / 0.4 ml
Ertapenem (Invanz) powder 1
Esomeprazole (Nexium) 40 mg
Fosfomycin powder 2 g
Furosemide inj 20 mg/ 2ml
Furosemide inj (High dose) 250 mg/25ml
Gentamicin 80 mg/2 ml
Haloperidol 5 mg/ ml
Heparin 25,000 units / 5 ml
Hydrocortisone powder 100 mg
Hysocine-N-butylbromide 20 mg/ml
Insulin : RI
Insulin : NPH , Mixtard
Imipenem (Tienam) powder 500 mg
Isoproterenol (Isuprel) 0.2 mg / 1 ml

11
11
11
11
11
11
12
12
12
12
12
13
13
13
12
13
13
14
14
14
14
15
15
15
15

Lincomycin 600 mg / 2 ml
Magnesium sulfate
Meropenem (Meronem) powder 1 g
Methylprednisolone (Solu-medrol) 1 g
Metoclopramide 10 mg/ 2 ml
Metronidazole 500 mg / 100 ml
Morphine sulfate 10 mg/ml
Moxifloxacin (Avelox) 400 mg/100ml
Multivitamin injection (OMVI)
Naloxone o.4 mg/ml
Neostigmine 12.5 mg / 5 ml
Netilmicin (Netromicin) 100 mg/ml
Nicardipine 10 mg / 10 ml
Nitroglycerin 25 mg / 5 ml
Octreotide (Sandostatin) 1000 g / 5ml
Omeprazole (Losec) powder 40 mg
Oxytocin 10 U/ml
Paracetamol 300 mg / 2 ml
Parecoxib (dynastat) powder 40 mg
Penicillin G sodium ; powder 1 mu, 5 mu
Pethidine 50 mg / ml
Pentazocine 30 mg / ml
Phenytoin (Dilantin) 250 mg / 5 ml
Potassium chloride 20 mEq / 10 ml
Pralidoxime (2-PAM) powder 1 g

15
16
16
16
17
17
17
17
17
17
18
18
18
18
18
19
19
19
19
19
19
20
20
20
20

Quinine dihydrochloride 600 mg / 2 ml

Ranitidine 50 mg/ 2 ml
Stilamin (Somatostatin) 3000 g
Streptokinase powder 1.5 mu
Streptomycin powder 1 g
Sodium bicarbonate 7.5 % in 50 ml
Sosium valproate (Depakine) 400 mg
Succinylcholine 500 mg
Sulperazone powder 1 g
Sulprostone (Nalador) 500 g
Tazocin 4.5 g
Terbutaline 0.5 mg / ml
Tramadol 50 mg / ml
Tranexamic acid 250 mg / 5ml
Vancomycin powder 500 mg
Vitamin K 2 mg / 0.2 ml
Vitamin K 10 mg / 1 ml
Vitamin C 500 mg in 2 ml
Benztropine Mesylate 1 mg/ml in 2 ml
Colistin 150 mg

20
21
21
21
22
22
22
22
22
23
23
23
23
23
24
24
24
24
25
25
25
Fondaparinux (Arixtra)2.5 mg/ 2.5 ml
Nadroparin (Fraxiparine)3800 IU/0.4 ml 25
25
Ondansetron 4 mg/2ml
25
Insulin : Detemir
25
Tigecycline 50 mg
2


1. IV bolus Sterile Water For Injection (SWFI) D5W NSS

2. IV infusion (solvent) D5W NSS
Imipenem D5W NSS D5W NSS
3. D5W NSS D5W NSS

4.
5. High Alert Drug High Alert Drug
6. D5W NSS D5W NSS

IM
= Intramuscular ( )
IV bolus
= Intravenous bolus ()
IV infusion
= Intravenous infusion (
SC
= Subcutaneous ()
After Reconstitution =
After Dilution
= D5W NSS

D5W
NSS
SWFI
NA

= 5% Dextrose in water
= Normal Saline Solution
= Sterile Water For Injection
= No data available

 D5W NSS
=
=
=

Acetylcysteine (Fluimucil) injection

Amoxycillin/Clavulonic (Augmentin) 1.2g
Amiodarone injection
Amphotericin B powder 50 mg
Ampicillin
Ertapenem (Invanz) 1 g
Esomeprazole (Nexium) 40 mg
Haloperidol injection
Insulin (RI) : Hyperglycemia
Meropenem (Meronem)
Morphine sulfate
Octreotide (Sandostatin)

Phenytoin (Dilantin)injection
Pralidoxime (2-PAM)
Streptokinase
Sulprostone (Nalador)

D5W

NSS

()

5
6
7
8
8
13
13
14
15
16
17
18
20
20
21
23
4

Acetylcysteine (Fluimucil) 300 mg / 3 ml

IV infusion : Paracetamol overdose
Acetylcysteine Paracetamol 8 15 .
150 mg/kg in 200 ml D5W 15
50 mg/kg in 500 ml D5W 4 .
100 mg/kg in 1000 ml D5W > 16 .
Acyclovir powder (Zovirax) 250 mg
IV infusion : 5 mg/ml
Adrenaline 1 mg/ml
IV infusion : refractory hypotension
1-20 g/min
0.1 1 g/kg/min

6 x weight(kg)xdesired dose (g/kg/min)

IV infusion rate (ml/hr)
= mg of drug to be added to 100 ml of IV fluid
IV bolus : 1 mg NSS 10 ml 5 10
SC / IM IM

(Solvent)
/
-

SWFI 10 ml

(Diluent)
D5W
NSS

200-1000 ml

100 ml

100 ml

infusion

1 .

(Stability)
After Reconstitution
After Dilution

2 8 C
2 8 C
24 .
-

12 .

Avoid

12 .

()

1 mg in
250 ml

1 mg in
250 ml

1-10 g/min

Avoid
()

24 .

24 .

1 g/min=15ml/hr
2 g/min=30ml/hr
3 g/min=45ml/hr

(Solvent)
/

(Diluent)
D5W
NSS

infusion

(Stability)
After Reconstitution
After Dilution

2 8 C
2 8 C

Adenosine (Adenocor) 6 mg / 2 ml
: IV ( 1-2 ) peripheral line 6 mg 1-2 2 12 mg 3
12 mg ( 12 mg )
(normal saline flush)
central line 3 mg
Antivenom sera
IV : SWFI 10 ml IV 2 ml / min
: 30 ml IV
2 ml/min 6 .
: 50 ml
100 ml IV 2 ml/min 12 .
IV infusion : NSS D5W 1 : 1 1 : 10 ( 1 ml antivenom to 1-10 ml infusion solution) 30 1 .
24 .
24 .
2
100 ml
100 ml
30 60
Amikacin 500 mg/ 2 ml
IV infusion :
IM
Amoxycillin/Clavulonic (Augmentin) 1.2g
IV infusion :
IV bolus : SWFI 20 ml
3 4

SWFI 20 ml

100 ml

30-40

20

4 .
At 25 C

8-12.5 .
At 5 C

(Solvent)
/
-

(Diluent)
D5W
NSS
50 250 ml
50 250 ml

1-5 mg/ml
1-5 mg/ml

infusion

Aminophylline 250 mg/10 ml

IV infusion :

0-6 wk : 5 mg/kg/day , 6wk-1mo: 12 mg/kg/day

6mo-1yr : 15 mg/kg/day
1-9yr : 1 mg/kg/hr
9-12yr , : 0.9 mg/kg/hr
12-16yr : 0.7 mg/kg/hr
: 0.5 mg/kg/hr
// : 0.25mg/kg/hr
IV bolus : Loading 5 mg / kg 20
( 20 -25 mg/min)
Amiodarone 150 mg / 3 m l
IV bolus : Loading dose 5 mg/kg 3 ()
IV infusion : Treatment and prophylaxis of ventricular tachycardia and ventricular fibrillation
1 : 300 mg in D5W 100 ml over 30-60 minutes then 600-900 mg in D5W 500 mlover 24 hours.
2 : 1000 mg 24 . 3
1 Rapid loading : 150 mg specifically diluted solution (1.5 mg/ml) over 10 minutes. Follow immediately with the slow loading
infusion
2 Slow loading infusion : 360 mg specifically diluted solution (1.8 mg/ml) at 1 mg/min over the next 6 hours
3 Maintenance infusion : 540 mg of 1.8 mg/ml solution at 0.5 mg/ml over 18 hours. Maintenance infusion is usually continued at
0.5 mg/min for 48 hours to 96 hours or until ventricular arrhythmias are stabilized. May be continued with caution for up to 2 to 3 weeks.
Transfer to oral therapy as soon as feasible.

(Stability)
After Reconstitution
After Dilution

2 8 C
2 8 C
24 .
-

1 : Dilute 150 mg (3 ml) in 100 ml D5W (1.5 mg/ml)

2-3 : Dilute 900 mg (18 ml) in 500 ml D5W (1.8 mg/ml)
Storage : Use solutions diluted in PVC container within 2 hours;
use those diluted in glass or polyolefin containers within 24
hours.

Amphotericin B powder 50 mg
IV infusion
Ampicillin powder 250 mg, 1 g
IV infusion :
IV bolus : 250 mg, 1 g SWFI 5 7.4 ml
IV 3-5 < 500 mg
10-15
IM : 250 mg, 1 g SWFI 0.9 3.4 ml
Atracurium besylate (Tracium) 50mg/5ml
IV infusion :
Initial 9-10 g/kg/min followed by 5-9 g/kg/min
IV bolus : Initial dose 0.4-0.5 mg/kg
0.5 1
Atropine sulfate 0.6 mg/ml
IV bolus : rapid IV
SC / IM
Azithromycin powder 500 mg
IV infusion
Calcium folinate (Leucovorin) powder 100 mg
IV bolus : 2 ml
IV infusion :

(Solvent)
-
SWFI 10 ml

(Diluent)
D5W
NSS
500 ml

(0.1 mg/ml)

infusion

SWFI 5 ml

100 ml
()

100 ml

15 30

100 ml
(0.5 mg/ml)

100 ml
(0.5 mg/ml)

24 .

24 .

SWFI 5 ml

250-500 ml

250-500 ml

1 .

24 .
(< 30C)

24 .

Bacteriostatic
WFI 5 ml

50 ml

50 ml

24 .
(conc.0.06-1
mg/ml)

4 - 6 .

Over 15 ml or
160 mg/ml

(Stability)
After Reconstitution
After Dilution

2 8 C
2 8 C
24 . (
7 (

) )

D5W : 1 .
D5W:4 .
1 .
4 .
NSS : 24 .
NSS : 5
(at 27 C)
(at 5 C)

Calcitonin Salmon 100 iu/ml

Osteoporosis, Pagets disease : 100-200 iu/day
SC / IM
Hypercalcemia : 5-10 iu / kg
IV bolus : slow IV 2-4 24 .
IV infusion : NSS 500 ml 6 .
Calcium gluconate 1 g / 10 ml (10%)
Rapid IV IV infusion
Cefazolin powder 1 g
IV infusion :
IV bolus : 1 g SWFI 7.5-10.5 ml 3-5
IM : 1 g SWFI 2.5 ml
Cefotaxime powder 500 mg, 1 g
IV infusion :
IV bolus : SWFI 10 ml 3-5
IM : 500 mg SWFI 2 ml
1 g SWFI 3 ml
Cefoxitin powder 1 g
IV infusion :
IV bolus : SWFI 10 ml 3-5
IM : SWFI 2 ml

(Solvent)
/
-

(Diluent)
D5W
NSS
100

infusion

(Stability)
After Reconstitution
After Dilution

2 8 C
2 8 C

6 .

1-2 g in
100 ml

1-2 g in
100 ml

30 60

24 .

SWFI 5 ml

50 100 ml

50 100 ml

30 60

24 .

10

24 .

96 .

SWFI 10 ml

50 100 ml

50 100 ml

30 60

12 .
( 25 C
protected
from light)

24 .
(protected
from light)

12 .
( 25 C
protected
from light)

24 .
(protected
from light)

SWFI 10 ml

50 100 ml

50 100 ml

30 60

24 .

7
( 5 C)

24 .

7
( 5 C)

Ceftazidime (Fortum) powder 1 g, 2 g

IV infusion :
IV bolus : SWFI 10 ml 3-5
IM : 1 g SWFI 3 ml
Ceftriaxone powder 1 g
IV infusion :
IV bolus : SWFI 10 ml 2 - 4
IM : 1 g SWFI 3.6 ml
1 g 1%lidocaine without epinephrine 3.5 ml

Chloramphenicol powder 1 g
IV infusion :
IV bolus : SWFI 10 ml 100
mg/ml 1
Chlorpheniramine 10 mg/ml
IV bolus
IM / SC
Chlorpromazine 50 mg in 2 ml
IV bolus : NSS
1 mg/ml 1 mg/min
0.5 mg/min
IM

(Solvent)
/
SWFI 10 ml

(Diluent)
D5W
NSS
50 100 ml
50 100 ml

infusion

SWFI 10 ml

50 100 ml

50 100 ml

30 - 60

6 .

24 .

10

SWFI
D5W 10 ml

50 100 ml

50 100 ml

30 - 60

30

24 .

30 60

(Stability)
After Reconstitution
After Dilution

2 8 C
2 8 C
7
24 .
7
24 .

10

Ciprofloxacin 200 mg / 100 ml

IV infusion
Clindamycin (Dalacin C) 300 mg/ 2 ml, 600 mg/ 4ml

IV infusion
IV infusion :
IM
Cloxacillin powder 500 mg, 1 g
IV infusion
phlebitis
IV infusion :
IV bolus : SWFI 10 ml 3-5
IM : 500 mg SWFI 2 ml
Dexamethasone 4 mg/ml
IV infusion :
IV bolus : 1
IM
Diazepam 10 mg/ 2 ml
IV bolus : 2-5 mg /
IM
Diclofenac 75 mg/ 3 ml
IM :

(Solvent)
/
-

(Diluent)
D5W
NSS
-

infusion

300 mg/50ml 300 mg/50ml

600mg/50ml 600mg/50ml
900mg/100ml 900mg/100ml
1200mg/100ml 1200mg/100ml

Over 10 min
Over 20 min
Over 30 min
Over 40 min

16

32 (4C)

60

24 .

48 .

NSS : 24 .
D5W : 8 .

24 .

SWFI 5 ml

100 ml

100 ml

4 -10 mg in 50 4 -10 mg in 50
ml
ml

1 .

(Stability)
After Reconstitution
After Dilution

2 8 C
2 8 C
-

11

Digoxin (Digoxin) 0.5 mg/2 ml (0.25 mg/ml)

Initial dose : 0.25 0.5 mg
Maintenance dose : 0.125 0.25 mg/day
IV bolus : 4
Digoxin 1 ml (0.25 mg) SWFI / NSS / D5W
4 ml 5
IV infusion :
IM :
Dimenhydrinate 50 mg / ml
IV bolus : IV NSS 10 ml
IV 2
IM
Dobutamine 250 mg / 20 ml
IV infusion
1 : 1 (Dobutamine 1 mg : Diluent 1 ml)
2 : 1 (Dobutamine 2 mg : Diluent 1 ml)
Dopamine 250 mg / 10 ml
IV infusion
1 : 1 (Dopamine1 mg : Diluent 1 ml)
2 : 1 (Dopamine2 mg : Diluent 1 ml)
Enoxaparin (Clexane) 40 mg / 0.4 ml
SC

(Solvent)
/
-

(Diluent)
D5W
NSS
50 ml
-

infusion
Over 20 min

(Stability)
After Reconstitution
After Dilution

2 8 C
2 8 C
48 .
If conc.
= 2.5 mg/L

10

250 ml

250 ml

2-40 g/kg/min

24 .

250 ml

250 ml

1-40 g/kg/min

24 .

12

Ertapenem (Invanz) powder 1 g

IV infusion :
IM : 3.2 . 1% 2%
lidocaine HCl injection ( epinephrine)
Esomeprazole (Nexium) 40 mg
IV bolus : IV 3
IV infusion :
Fosfomycin powder 2 g
IV bolus : SWFI/ D5W/ NSS 20 ml 5
IV infusion :
Furosemide inj 20 mg/ 2ml
IV bolus : 20 - 40 mg 1-2
IM
Furosemide inj (High dose) 250 mg/25ml
IV infusion :
Gentamicin 80 mg/2 ml
IV infusion :
IM

(Solvent)
/
SWFI NSS
10 ml

(Diluent)
D5W
NSS
50 ml

infusion
30

(Stability)
After Reconstitution
After Dilution

2 8 C
2 8 C

6 .
24 .
(25 C)
(5 C)
4 .

NSS 5 ml

100 ml

10-30

12 .
(< 30 C)

12 .
(< 30 C)

12 .
(< 30 C)

12 .
(< 30 C)

SWFI
D5W NSS
20 ml

100 500 ml

100 500 ml

1 2 .

1-2 mg/ml

1-2 mg/ml

4
mg/min
250 mg : 1 .
30 60

24 .

Avoid

50-250 ml
50-250 ml

1 mg/ml
1 mg/ml

()

24 .

13

Haloperidol 5 mg/ ml
IV infusion :
IV bolus : 5 mg/min
IM
Heparin 25,000 units / 5 ml
IV infusion :
IV bolus : 1-2
SC

Hydrocortisone powder 100 mg

IV infusion :
IV bolus: SWFI / D5W / NSS 2 ml
30
IM : SWFI / NSS 2 ml
Hysocine-N-butylbromide 20 mg/ml
IV bolus: SWFI 3-5 ml 1
SC / IM

(Solvent)
/
-

(Diluent)
D5W
NSS

0.5100 mg
50 100 ml

25,000 U
25,000 U

250 , 500 ml 250 , 500 ml

100 U / ml , 50 100 U / ml , 50
U /ml
U /ml

SWFI
D5W NSS 0.1 1 mg/ml 0.1 1 mg/ml
100 mg in 100 mg in
2 ml
100 ml
100 ml
-

infusion
1-40 mg/hr

(Stability)
After Reconstitution
After Dilution

2 8 C
2 8 C
24 .
-

1000 U / hr

15-18 U/kg/hr

24 .

24 .

20 30

3 (
)

3 (
)

24 .

14

Insulin : RI : Actrapid / Humulin R 1000 units / 10 ml

SC / IM / IV bolus
IV infusion :
( Hyperglycemia)
Insulin :NPH :Insulatard / Humulin N 1000 units/10 ml
Mixtard 300 units / 3 ml

Mixtard
SC
Imipenem (Tienam) powder 500 mg
IV infusion

(Solvent)
/
-

Isoproterenol (Isuprel) 0.2 mg / 1 ml

SC / IM / Intracardiac / IV infusion / IV bolus
26-27

Lincomycin 600 mg / 2 ml
IV infusion :
Deep IM

(Diluent)
D5W
NSS
1 Unit : 1 ml

100 Unit in
100 ml
-

infusion
0.05-0.2
Unit/kg/hr

(Stability)
After Reconstitution
After Dilution

2 8 C
2 8 C
24 .
24 .

10 ml
10 ml

100 ml
100 ml
-

500 mg
20 30
1 g
40 60

4 .

24 .

4 .

24 .

100 ml
100 ml
< <
1 g /100 ml
1 g /100 ml

1 .

24 .

15

Magnesium sulfate
10 % 10 ml (1 g)
IV infusion :
IV bolus : 1.5 ml / min
50 % 2 ml (1 g)
IV infusion :
IM
Meropenem (Meronem) powder 1 g
IV bolus : SWFI 20 ml IV 3- 5
IV infusion :
Methylprednisolone (Solu-medrol) 1 g

16 ml ( 62.5 mg/ml)
IM
IV bolus : 125 mg : Direct IV 3-15
IV infusion :
125 500 mg 15-30
500-1000 mg > 30
> 1000 mg > 60
spinal cord injury 8 .
30 mg/kg IV bolus over 15 min 45
continuous IV infusion 5.4 mg/kg/hr 23 .

(Solvent)
/
-

(Diluent)
D5W
NSS
1-20 g in
1-20 g in
50 1000 ml 50 1000 ml

infusion

SWFI 20 ml

50 100 ml

50 100 ml

Maximum rate
of infusion :
1 -2 g/hr
Maximum dose
should not
exceed 30-40
g/day
15 30

> 50 ml

> 50 ml

(Stability)
After Reconstitution
After Dilution

2 8 C
2 8 C
60
-

8 .
(1525 C)

48 .

D5W: 3 .
NSS : 8 .

D5W:14 .
NSS : 48 .

48 .

48 .

16

Metoclopramide 10 mg/ 2 ml
IV infusion : > 10 mg
IV bolus : 1-2
IM
Metronidazole 500 mg / 100 ml
IV infusion
Morphine sulfate 10 mg/ml
IV infusion :
IV bolus : SWFI 4 - 5 ml 3-5
SC / IM

(Solvent)
/
-

(Diluent)
D5W
NSS
50 ml
50 ml

infusion
15

(Stability)
After Reconstitution
After Dilution

2 8 C
2 8 C
24 .
-

60

0.1 1 mg/ml
in D5W

0.810 mg/hr may

increase depending
on pain relief /
adverse effect ;
usual range up to
80 mg/hr

NA

NA

24 .

60
Moxifloxacin (Avelox) 400 mg/100ml
IV infusion
Multivitamin injection (OMVI)
2 1 12 .
Naloxone The
Naloxone
Naloxone o.4 mg/ml
administration
2 mg
2 mg
IV infusion : high dose
rate should be
500 ml
500 ml
IV bolus / SC / IM
( 4 g/ml) titrated to the
( 4 g/ml)
patient s
response

17

Neostigmine 12.5 mg / 5 ml
IV bolus : 0.5 mg /
SC / IM
Netilmicin (Netromicin) 100 mg/ml
IM / IV infusion
Nicardipine 10 mg / 10 ml
IV infusion 1 : 10 1 : 5
1 : 10 Nicardipine 1 mg : Diluent 10 ml
1 : 5 Nicardipine 1 mg : Diluent 5 ml
IV bolus : 1 mg 1-2
Nitroglycerin 25 mg / 5 ml
IV infusion 1 : 10 1 : 5
1 : 10 Nitroglycerin 1 mg : Diluent 10 ml
1 : 5 Nitroglycerin 1 mg : Diluent 5 ml
Octreotide (Sandostatin) 1000 g in 5 ml
Continuous IV infusion :
bleeding gastro-esophageal varices 25 50 g/hr
5
SC
50 g (0.05 mg) = 0.25 ml
100 g (0.1 mg) = 0.5 ml

(Solvent)
/
-

(Diluent)
D5W
NSS
-

infusion
-

(Stability)
After Reconstitution
After Dilution

2 8 C
2 8 C
-

50 100 ml

50 100 ml

30 60

10 mg:100 ml
10 mg:50ml

10 mg:100 ml
10 mg:50ml

5 15 g/hr

24 .

250 500 ml 250 500 ml 5 200 g/min

48 .

24 .
(< 25 C)

24 .

5, 50, 100
g/ml
()

5, 50, 100
g/ml

24 .

18

Omeprazole (Losec) powder 40 mg

IV bolus: 2.5
IV infusion :
Oxytocin 10 U/ml
IV infusion :
IM : Total dose of 10 units after delivery
Paracetamol 300 mg / 2 ml IM
Parecoxib (dynastat) powder 40 mg
IM / IV bolus
Penicillin G sodium ; powder 1 mu, 5 mu
IM : 100,000 U/ml
IV infusion : 10 mu / day
D5W NSS 1-2 infusion
24 . 1/6 1/4
4 6 . 1-2 .
Pethidine 50 mg / ml
IV bolus : slowly
IV infusion : 1 mg/ml has been used as a
supplement to a anesthesia ( D5W/NSS)
SC / IM

(Solvent)
/
SWFI 10 ml

(Diluent)
D5W
NSS
90 ml
90 ml

infusion

1 ml 1 ml

1000 ml
1000 ml

1-2 milliunit /
min 1530
20
milliunit / min

20-30

(Stability)
After Reconstitution
After Dilution

2 8 C
2 8 C
4 .
NA
NA

NSS 2 ml

12 .

SWFI 10 ml

2 mu/50ml
2.1-6 mu/100 ml

2 mu/50ml
2.1-6 mu/100 ml

1 .
15-30

24 .

24

19

Pentazocine 30 mg / ml
SC / IM / IV bolus
Phenytoin (Dilantin) 250 mg / 5 ml
IV bolus : 50 mg/min
1-3 mg/kg/min normal saline flush

IV infusion :
Potassium chloride 20 mEq / 10 ml
IV infusion

Pralidoxime (2-PAM) powder 1 g

IV infusion :
IV bolus : pulmonary edema
infusion SWFI
20 ml 5
Quinine dihydrochloride 600 mg / 2 ml
IV infusion : Loading & Maintenance
Loading dose : 20 mg/kg 2 amp D5W/ NSS
500 ml
Maintenance dose : 10 mg/kg 8 . 7 1 amp
D5W / NSS 200 ml

(Solvent)
/
-

D5W
-

NSS
-

50-100 ml
(
1-10 mg/ml)

maximum
concentration
40 mEq /Lit

maximum
concentration
40 mEq /Lit

1 .
Maximum rate
50 mg/min

10-20 mEq / hr

40 mEq/hr

SWFI 20 ml

100 ml

(Diluent)

200 -500 ml

200 -500 ml

infusion
-

(Stability)
After Reconstitution
After Dilution

2 8 C
2 8 C
-

4 .

pH
< 11.5

24 .

30

Loading dose :
4 .
Maintenance
dose
2 . q 8 hr

20

Ranitidine 50 mg/ 2 ml
Continuous IV infusion :
Intermittent IV infusion : 50 mg D5W / NSS
100 ml drip 15-20
IV bolus : Ranitidine 50 mg D5W NSS 20 ml
5
IM
Stilamin (Somatostatin) 3000 g
1. NSS
2. D5W NSS 500 ml
3. 250 g IV bolus + IV infusion 250 g / hr
40 ml IV
3-5 drip
40 ml / hr 11 .
4. 1-2 IV infusion 40 ml/hr
12 .
Streptokinase powder 1.5 mu
IV infusion :

(Solvent)
/
-

NSS

D5W or
NSS (prefer)
5 ml

(Diluent)

infusion

(Stability)
After Reconstitution
After Dilution

2 8 C
2 8 C
24 .
-

D5W
150 mg in
250 ml
(
2.5
mg/ml)

NSS
150 mg in
250 ml
(
2.5
mg/ml)

500 ml
(6g/ml)

500 ml
(6g/ml)

12 .

24 .

5 ml

50-100
ml

5 ml

50-100
ml
(prefer)

60

24 .

8 .

24 .

6.25 mg/hr for

24 hr

21

Streptomycin powder 1 g IV
IM : 1 g SWFI 3.5 4.5 ml deep IM
into large muscle mass
Sodium bicarbonate 7.5 % in 50 ml
IV bolus : 2
D5W 1 : 1
Intermittent IV :
D5W 4-8 .
Sodium Valproate (Depakine) 400 mg
IV bolus : 3
IV infusion :
Succinylcholine 500 mg
IV bolus :
IV infusion : 0.10.2 % (1-2 mg/ml)
D5W / NSS 0.5 10 mg/min
Sulperazone powder 1 g
IV infusion :
IV bolus : SWFI 3.4 ml 3
IM : SWFI
2% Lidocaine without adrenaline

(Solvent)
/
-

(Diluent)

infusion

D5W
-

NSS
-

24 .

SWFI 4 ml

50 ml

50 ml

60
20
mg/min

24 .

250-1000 ml
(1-2 mg/ml)

250-1000 ml
(1-2 mg/ml)

0.5 10 mg/min

24 .

SWFI
D5W NSS
3.4 ml

16 ml

16 ml

15 60

24 .
15 30 C

(Stability)
After Reconstitution
After Dilution

2 8 C
2 8 C
2
48 .

24 .
15 30 C

22

Sulprostone (Nalador) 500 g

IV infusion : (0.9 % NSS 2 ml)

Tazocin 4.5 g
IV bolus : 3-5
IV infusion :
Terbutaline 0.5 mg / ml
IV infusion : D5W NSS
Dextrose
SC
Tramadol 50 mg / ml
SC / IM / IV bolus : 1 ml/min
Tranexamic acid 250 mg / 5ml
IV bolus : 1-2 ( hypotension)
IV infusion : During or after operation, if necessary, 2-10
ampules (2-10 ml) are given by IV drip infusion

IM :

(Solvent)
/
NSS 2 ml

(Diluent)

infusion

(Stability)
After Reconstitution
After Dilution

2 8 C
2 8 C
12 .
-

D5W

NSS
1 amp
250 ml / 500
ml

50-150 ml

50-150 ml

20-30

12 .

48 .

NA

NA

10 amp
1000 ml
( 5 g/min)

10 amp
1000 ml
(g/min)

10 g/min

48 .

SWFI NSS
D5W
20 ml
-

100
g/hr (
NSS 250
ml 17 drop
/min)
500
g/hr (80 drop
/min)

23

(Solvent)
/
SWFI
500 mg/ 10 ml
1 g/ 20 ml

(Diluent)
D5W
NSS

infusion

(Stability)
After Reconstitution
After Dilution

2 8 C
2 8 C
14
14
7
7

> 2 .
Vancomycin powder 500 mg
500 mg/100 ml
Intermittent IV infusion :
> 500 mg / 250 ml
Continuous IV infusion : 1-2 g
D5W / NSS
24 .
Vitamin K 2 mg / 0.2 ml
(Konakian MM Pediatric) 1
Oral : 2 mg 2 mg 4-7 2 mg 4-6
IM : 1 mg (0.1 ml) 2 3
IV bolus : 1 mg
Vitamin K 10 mg / 1 ml (Konakian)
IV bolus : 0.9% NSS D5W ( 30 )
Oral : 0.5 1 ml 8-12 . 2 2 ml
IM :
Vitamin C 500 mg in 2 ml
IV bolus : 100 mg/min (avoid rapid IV injection)
IV infusion : D5W / NSS
IM

24

Benztropine Mesylate 1 mg/ml in 2 ml

IM / IV
Colistin 150 mg
IM
Direct IV over 3-10 minutes
Intermittent IV infusion :over 30 minutes
Continuous IV infusion : 24 .
Fondaparinux (Arixtra) 2.5 mg / 2.5 ml
SC
Nadroparin (Fraxiparine) 3800 IU / 0.4 ml
SC
Ondansetron 4 mg/2ml
IM / IV
Insulin : Detemir
SC
Tigecycline 50 mg
IV infusion : 50 mg D5W / NSS 100 ml
()
100 mg 2
IV bag for infusion 100 ml

(Solvent)
/
-

(Diluent)
D5W
NSS
-

infusion
-

(Stability)
After Reconstitution
After Dilution

2 8 C
2 8 C
-

SWFI 2 ml

fluid

fluid

30

Freshly
prepare and
use within
24 hours

NSS 5.3 ml Or
D5W 5.3 ml

5 ml
NSS
D5W

100 ml

100 ml

30-60

24 .
( 6 .

18 .
IV
bag)

45 .
(

IV bag )

25

 Isuprel 0.2 mg/ml (1:5000)

Recommended dosage for adults with heart block, Adams-Stokes attacks and cardiac arrest
Route of Administration

Preparation of Dilution

Initial Dose

Subsequent Administration
Dose Range*
Bolus intravenous
Dilute 1 ml of solution 1:5000
0.02 mg to 0.06 mg (1 ml to 3 0.01 mg to 0.2 mg (0.5 ml to
injection
(0.2 mg) to 10 ml with Sodium
ml of diluted solution
10 ml of diluted solution)
Chloride or 5% Glucose injection
1:50,000)
Intravenous infusion
Dilute 10 ml of solution 1:5000
5 g/min (1.25 ml of diluted
(2 mg) in 500 ml with Sodium
solution 1:250,000 per
Chloride or 5% Glucose injection
minute)
Intramuscular
Use solution 1:5000 undiluted
0.2 mg (1 ml)
0.02 mg to 1 mg
(0.1 ml to 5 ml)
Subcutaneous
Use solution 1:5000 undiluted
0.2 mg (1 ml)
0.15 mg to 0.2 mg
(0.75 ml to 1 ml)
Intracardiac
Use solution 1:5000 undiluted
0.02 mg (0.1 ml)
* Subsequent dosage and method of administration depend on the ventricular rate and the rapidity with which the cardiac pacemaker
can take over when the drug is gradually withdrawn. There are no well-controlled studies in children to establish appropriate dosing;
however, the American Heart Association recommends an initial infusion rate of 0.1 g/kg/min to 1 g/kg/min

26

Recommended dosage for adults with shock and hypoperfusion states

Route of Administration
Intravenous infusion

Preparation of Dilution +
Infusion rate ++
Dilute 5 ml (1 mg) in 500 ml of 5%
0.5 g to 5 g per minute (0.25 ml to
Glucose injection
2.5 ml of diluted solution)
+ Concentrations up to 10 times greater have been used when limitation of volume is essential
++ Rates over 30 g per minute have been used in advanced stages of shock. The rate of infusion should be adjusted on the basis of
heart rate, central venous pressure, systemic blood pressure, and urine flow. If the heart rate exceed 110 beats per minute, it may be
advisable to decrease or temporarily discontinue the infusion

Recommended dosage for adults with bronchospasm occurring during anesthesia

Route of Administration
Bolus intravenous
injection

Preparation of Dilution
Dilute 1 ml (0.2 mg) to 10 ml with
Sodium Chloride or 5% Glucose
injection

Initial Dose

Subsequent Administration
Dose Range*
0.01 mg to 0.02 mg (0.5 ml to The initial dose may be
1 ml of diluted solution)
repeated when nessary.

27

28